Products - Psychosis and schizophrenia | Topic | NICE

Showing 2 products

Date | Title

Advice programme: Evidence summariesRemove ‘Advice programme: Evidence summaries’ filter

Schizophrenia: lurasidone (ESNM48)
Product type:
Advice
Programme:
Evidence summary
Published:
23 September 2014
Schizophrenia: omega-3 fatty acid medicines (ESUOM19)
Product type:
Advice
Programme:
Evidence summary
Published:
24 September 2013